Tyra Biosciences Stock Target Price and Analyst Consensus
| TYRA Stock | USD 31.40 1.23 4.08% |
The current analyst and expert consensus on Tyra Biosciences is Strong Buy, with 6 strong buy opinions. The current projected Tyra Biosciences target price consensus is 34.86 with 8 analyst opinions. Check out Macroaxis Advice on Tyra Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Tyra Stock refer to our How to Trade Tyra Stock guide.The most common way Tyra Biosciences analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Tyra Biosciences executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Tyra Biosciences. We strongly encourage you to use your own analysis of Tyra Biosciences to validate this buy or sell advice. Tyra Biosciences buy-or-sell recommendation module provides average expert sentiment on the projected Tyra Biosciences target price to derive its highest and lowest estimates based on projected price volatility of 4.6403.
Lowest Forecast 31.72 | Highest Forecast 38.69 | Target Price 34.86 |
It's important to approach Tyra Biosciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Tyra Biosciences Target Price Consensus
Tyra target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Tyra Biosciences' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 8 | Strong Buy |
Most Tyra analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Tyra stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Tyra Biosciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationTyra Biosciences Target Price Projection
Tyra Biosciences' current and average target prices are 31.40 and 34.86, respectively. The current price of Tyra Biosciences is the price at which Tyra Biosciences is currently trading. On the other hand, Tyra Biosciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Tyra Biosciences Market Quote on 27th of January 2026
Target Price
Analyst Consensus On Tyra Biosciences Target Price
Tyra Biosciences Analyst Ratings
Tyra Biosciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Tyra Biosciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Tyra Biosciences' financials, market performance, and future outlook by experienced professionals. Tyra Biosciences' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Tyra Biosciences price targets
Tyra Biosciences' stock target price is an estimate of its future price, usually made by analysts. Using Tyra Biosciences' target price to determine if it is a suitable investment can be done through the following steps:- Look at Tyra Biosciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Tyra Biosciences' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Tyra Biosciences Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Tyra Biosciences is a key component of Tyra Biosciences valuation and have some predictive power on the future returns of a Tyra Biosciences.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 100 shares | |
 | FinTech Invested over 50 shares | |
 | Impulse Invested over 200 shares | |
 | Dividend Beast Invested over 30 shares | |
 | Driverless Cars Invested few shares | |
 | Hedge Favorites Invested over 30 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Social Domain Invested few shares |
Check out Macroaxis Advice on Tyra Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Tyra Stock refer to our How to Trade Tyra Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Please note, the presentation of Tyra Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tyra Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Tyra Biosciences' management manipulating its earnings.